Bioprinting towards Organ Fabrication: Challenges and Future Trends.

IEEE transactions on bio-medical engineering (Impact Factor: 2.15). 01/2013; DOI: 10.1109/TBME.2013.2243912
Source: PubMed

ABSTRACT Tissue engineering has been a promising field of research, offering hope for bridging the gap between organ shortage and transplantation needs. However, building three-dimensional (3D) vascularized organs remains the main technological barrier to be overcome. Organ printing, which is defined as computer-aided additive biofabrication of 3D cellular tissue constructs, has shed light on advancing this field into a new era. Organ printing takes advantage of rapid prototyping (RP) technology to print cells, biomaterials, and cell-laden biomaterials individually or in tandem, layer by layer, directly creating 3D tissue-like structures. Here, we overview RP-based bioprinting approaches and discuss the current challenges and trends towards fabricating living organs for transplant in the near future.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper highlights the development of ‘Multi-arm Bioprinter (MABP)’ capable of concurrent multi-material deposition with independent motion path and dispensing parameters including deposition speed, material dispensing rate, and nozzle travel velocity for use in tissue engineering. In this research, the system is designed to concurrently print a filament structure and deposit cell spheroids between the filaments to create a hybrid structure to support the cell spheroids in three dimensions (3Ds). This process can be used with multiple cell types and is capable of reducing the fabrication time while using optimized dispensing parameters for each material. A novel method of dispensing the crosslinking solution using a co-axial nozzle was also developed and demonstrated in this paper. Cell-laden structures were fabricated through concurrent deposition of cell-encapsulated filaments and with cell spheroids to validate this concept. Rheology studies were then conducted to determine the effects of crosslink flow on filament width, hydrogel dispensing pressure on filament width, and dispensing time interval on spheroid diameter.
    Robotics and Computer-Integrated Manufacturing 01/2014; 30(3):295–304. · 1.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tissue and organ replacement is required when there are no alternative therapies available. Although vascular tissue engineering was originally developed to meet the clinical demands of small-diameter vascular conduits as bypass grafts, it has evolved into a highly advanced field where perfusable vasculatures are generated for implantation. Herein, we review several cutting-edge techniques that have led to implantable human blood vessels in clinical trials, the novel approaches that build complex perfusable microvascular networks in functional tissues, the use of stem cells to generate endothelial cells for vascularization, as well as the challenges in bringing vascular tissue engineering technologies into the clinics.
    Current opinion in chemical engineering. 02/2014; 3:68-74.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Organ printing, takes tissue spheroids as building blocks together with additive manufacturing technique to engineer tissue or organ replacement parts. Although a wide array of cell aggregation techniques has been investigated, and gained noticeable success, the application of tissue spheroids for scale-up tissue fabrication is still worth investigation. In this paper, we introduce a new micro-fabrication technique to create tissue strands at the scale of 500-700μm as a "bioink" for future robotic tissue printing. Printable alginate micro-conduits are used as semi-permeable capsules for tissue strand fabrication. Mouse insulinoma beta TC3 cell tissue strands were formed upon 4 days post fabrication with reasonable mechanical strength, high cell viability close to 90%, and tissue specific markers expression. Fusion was readily observed between strands when placing them together as early as 24h. Also, tissue strands were deposited with human umbilical vein smooth muscle cells (HUVSMCs) vascular conduits together to fabricated miniature pancreatic tissue analog. Our study provided a novel technique using tissue strands as "bioink" for scale-up bioprinting of tissues or organs.
    The 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC’14), Chicago, Illinois, USA; 08/2014


Available from
Aug 22, 2014
Available from